jRCT1052200052已完成不适用
Japanese HIS-bundle pacing for patient with indication of Cardiac Resynchronization Therapy Trial
未提供0 个研究点目标入组 50 人开始时间: 2021年3月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 No limit(—)
- 性别
- All
入选标准
- •Subject is 20 years of age or older at the time of consent acquisition
- •Subject who meets CRT indications according to the guidelines of the Japanese Circulation Society
- •Subject planning to implant CRT
- •Subject has signed and dated the informed consent form
排除标准
- •Subject with a history of CRT implantation
- •Subject with severe heart failure that requires continuous administration of cardiotonic
- •Subject with unstable angina, acute myocardial infarction within 40 days, or within 3 months after coronary artery invasive treatment
- •Subject scheduled for tricuspid valve surgery
- •Pregnant woman
- •Subject participating in other clinical trials or intervention trials
- •Subject judged to be inappropriate to this study for other reasons by the investigator
结局指标
主要结局
-
Responder rate 6 months after implantation
次要结局
- Amount of change in cardiac function by myocardial scintigraphy(6 months after implantation)
- Prognosis(6 and 24 months after implantation)
研究者
相似试验
进行中(未招募)
不适用
W-JHS HL01jRCTs07120009260
已完成
不适用
Japanese multicenter REsearch of COVID-19 by assEmbling Real-world dataCOVID-19JPRN-UMIN000047056ippon Medical School Musashikosugi Hospital4,700
招募中
不适用
J-TRC onsite studypreclinical and prodromal Alzheimer's diseaseJPRN-UMIN000038711AMED1,200
招募中
不适用
HED-TRC (HED-TRC)jRCT1031230633PDRadiopharma Inc.55
尚未招募
不适用
Premarket study to assess safety and performance of the Orion Magnetic Localization System for breast cancerBreast CancerNL-OMON24152Sirius Medical Systems B.V.30
